ALICIA FULBRIGHT: Open Payments
NPI 1902417728 · ETOWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 55 payments from 22 companies in 2025. Trend: 2023 $926 · 2024 $1,072 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $186 |
| Novo Nordisk Inc | 5 | $104 |
| Lilly USA, LLC | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| HEARTFLOW, INC. | 2 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Amgen Inc. | 3 | $45 |
Products named: VRAYLAR, JARDIANCE, Kerendia, XIFAXAN, FFRct, CAPLYTA, FARXIGA, NEXLETOL.
Industry payments across TN — which companies pay providers there.
